Publications dans lesquelles il/elle collabore avec Francisco Soriano García (15)

2011

  1. Cefditoren in upper and lower community-acquired respiratory tract infections

    Drug Design, Development and Therapy, pp. 85-94

2008

  1. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1234-1240

2005

  1. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs Differ

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 3, pp. 996-1001

  2. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: A phase I, open-label, noncomparative clinical trial in healthy volunteers

    Clinical Therapeutics, Vol. 27, Núm. 7, pp. 1043-1049

2004

  1. In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae

    International Journal of Antimicrobial Agents, Vol. 23, Núm. 1, pp. 25-31

2003

  1. Does Acetaminophen Interfere in the Antibiotic Treatment of Acute Otitis Media Caused by a Penicillin-Resistant Pneumococcus Strain? A Gerbil Model

    Pediatric Research, Vol. 54, Núm. 6, pp. 913-918

  2. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility

    International Journal of Antimicrobial Agents, Vol. 21, Núm. 6, pp. 568-573

  3. Is it possible to achieve bacterial eradication in otitis media with effusion by empirical antibiotic high doses and concomitant administration of acetaminophen? A microbiological and pharmacological study in the gerbil model

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 508-515

2002

  1. Optimal dose of Amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 3, pp. 859-862

  2. Urine bactericidal activity after administration of gemifloxacin and trovafloxacin single doses in a phase I study [2]

    International Journal of Antimicrobial Agents, Vol. 20, Núm. 6, pp. 477-480

2001

  1. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: Phase I study

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 6, pp. 1876-1878

  2. Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 2, pp. 608-611

2000

  1. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model

    Journal of Infectious Diseases, Vol. 181, Núm. 2, pp. 646-652

1999

  1. Antimicrobial treatment of an experimental otitis media caused by a β-lactamase positive isolate of Haemophilus influenzae

    Journal of Antimicrobial Chemotherapy, Vol. 44, Núm. 1, pp. 85-90

1998

  1. In vivo efficacies of amoxicillin and cefuroxime against penicillin- resistant Streptococcus pneumoniae in a gerbil model of acute otitis media

    Antimicrobial Agents and Chemotherapy, Vol. 42, Núm. 6, pp. 1361-1364